UnknownNCT05028270

Treatment of Intraocular Retinoblastoma

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Principal Investigator
Min Shi
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Intervention
Balloon technology;Microcatheter technology(procedure)
Enrollment
1600 enrolled
Eligibility
1-18 years · All sexes
Timeline
2022 – 2023

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05028270 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials